financetom
Business
financetom
/
Business
/
Morgan Stanley questioned by US House panel over Zijin Gold IPO in Hong Kong 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morgan Stanley questioned by US House panel over Zijin Gold IPO in Hong Kong 
Nov 14, 2025 9:13 AM

NEW YORK (Reuters) -Morgan Stanley's ( MS ) underwriting of Zijin Gold International's Hong Kong IPO placed it and its U.S. investors at risk of regulatory, financial and reputational harm, a U.S. House of Representatives committee told the bank on Thursday. 

Zijin Gold is a subsidiary of Zijin Mining Group, a global mining company based in China that is on a U.S. government list of companies whose imports are banned over alleged human rights abuses involving Uyghurs. 

In September, Morgan Stanley ( MS ) assisted with Zijin Gold's IPO to help its parent company raise funds by selling its non-Chinese gold mining assets and listing them on the Hong Kong Stock Exchange, the House's select committee on China said. That raised questions of whether it helped Zijin Mining evade the U.S. prohibitions, according to the committee.

Morgan Stanley ( MS ) declined to comment. Zijin Gold and Zijin Mining did not immediately respond to requests for comment.

"When U.S. financial institutions engage with Chinese firms linked to Uyghur forced labor, they undermine the U.S. government's goal of deterring forced labor globally," Representative John Moolenaar, the committee's chair, wrote in a letter to Morgan Stanley ( MS ) CEO Ted Pick.

In January, Zijin Mining was added to the Uyghur Forced Labor Prevention Act Entity List, which restricts imports tied to what the U.S. says is an ongoing genocide of minorities in China's western Xinjiang region. 

U.S. officials say Chinese authorities have established labor camps for Uyghurs and other Muslim minority groups in Xinjiang. Beijing denies any abuses. 

In the letter, Moolenaar seeks documents and communications about Morgan Stanley's ( MS ) involvement in the public offering related to the company's links to the Chinese government, Chinese Communist Party, military, and human rights abuses. He asked for the information by November 27. 

The letter is the latest action by his committee on U.S. financial institutions' involvement in underwriting IPOs of Chinese companies with ties to the Chinese military or to illegal labor practices.

In July, the committee subpoenaed documents from JPMorgan and Bank of America over their roles in underwriting the Hong Kong IPO of China's CATL, the world's largest electric vehicle battery maker. CATL has been designated a Chinese military company by the U.S. Department of Defense.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Clearmind Says US Patent Application Published Targeting Binge Behavior Disorders
Clearmind Says US Patent Application Published Targeting Binge Behavior Disorders
Oct 20, 2025
08:09 AM EDT, 10/20/2025 (MT Newswires) -- Clearmind Medicine ( CMND ) said Monday that a US patent application has been published by the US Patent and Trademark Office for its innovative combination therapy of 5-methoxy-2-aminoindane and N-Acylethanolamines, such as Palmitoylethanolamide, targeting binge behavior disorders. The clinical-stage biotech company said this patent application stems from its ongoing collaboration with SciSparc...
HBT Financial, CNB Bank Shares Agree to $170.2 Million Cash, Stock Merger
HBT Financial, CNB Bank Shares Agree to $170.2 Million Cash, Stock Merger
Oct 20, 2025
08:05 AM EDT, 10/20/2025 (MT Newswires) -- HBT Financial ( HBT ) and CNB Bank Shares said Monday that they have agreed to a $170.2 million cash and stock merger. Under the terms of the agreement, CNB shareholders will receive either 1.0434 HBT common shares for each CNB share, or $27.73 per share in cash, or a combination of cash...
AbbVie's Rinvoq shows superiority over Humira in head-to-head study
AbbVie's Rinvoq shows superiority over Humira in head-to-head study
Oct 20, 2025
Oct 20 (Reuters) - AbbVie ( ABBV ) said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, meeting the main goal of a head-to-head trial. (Reporting by Puyaan Singh in Bengaluru) ...
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
Oct 20, 2025
Cohen and Associates has more than a decade of leadership in interventional psychiatry and Transcranial Magnetic Stimulation (TMS) Dr. Rebecca Cohen has joined HOPE as Medical DirectorImmediate expansion is planned in Western Florida and Palm BeachAcquisition expected to be accretive to HOPE Therapeutics revenue and EBITDA MIAMI, Oct. 20, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. (HOPE), an interventional psychiatry...
Copyright 2023-2026 - www.financetom.com All Rights Reserved